USP22 and cancer: Ubiquitin-specific protease 22 (USP22) was identified as a member of the so-called 11-gene “death-from-cancer” expression signature which was associated with distant metastasis, high recurrence rates and poor patient survival in several cancer entities, including CRC [5,6].